Insulin resistance and the metabolism of branched-chain amino acids

doi:10.1007/s11684-013-0255-5

Front Med

2013, Vol. 7

Issue (1) : 53-59 https://doi.org/10.1007/s11684-013-0255-5

REVIEW

Insulin resistance and the metabolism of branched-chain amino acids

Jingyi Lu¹, Guoxiang Xie^2,3, Weiping Jia¹, Wei Jia^2,3(

)

1. Shanghai Diabetes Institute; Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital; Shanghai Key Laboratory of Diabetes Mellitus; Shanghai Clinical Center for Diabetes, Shanghai 200233, China; 2. Center for Translational Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai 200233, China; 3. Center for Translational Biomedical Research, University of North Carolina at Greensboro, North Carolina Research Campus, Kannapolis, NC 28081, USA

Download: PDF(196 KB) HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks

Abstract

Insulin resistance (IR) is a key pathological feature of metabolic syndrome and subsequently causes serious health problems with an increased risk of several common metabolic disorders. IR related metabolic disturbance is not restricted to carbohydrates but impacts global metabolic network. Branched-chain amino acids (BCAAs), namely valine, leucine and isoleucine, are among the nine essential amino acids, accounting for 35% of the essential amino acids in muscle proteins and 40% of the preformed amino acids required by mammals. The BCAAs are particularly responsive to the inhibitory insulin action on amino acid release by skeletal muscle and their metabolism is profoundly altered in insulin resistant conditions and/or insulin deficiency. Although increased circulating BCAA concentration in insulin resistant conditions has been noted for many years and BCAAs have been reported to be involved in the regulation of glucose homeostasis and body weight, it is only recently that BCAAs are found to be closely associated with IR. This review will focus on the recent findings on BCAAs from both epidemic and mechanistic studies.

Keywords branched-chain amino acids leucine isoleucine valine insulin resistance

Corresponding Author(s): Jia Wei,Email:w_jia@uncg.edu

Issue Date: 05 March 2013

Cite this article:

Jingyi Lu,Guoxiang Xie,Weiping Jia, et al. Insulin resistance and the metabolism of branched-chain amino acids[J]. Front Med, 2013, 7(1): 53-59.

URL:

https://academic.hep.com.cn/fmd/EN/10.1007/s11684-013-0255-5
https://academic.hep.com.cn/fmd/EN/Y2013/V7/I1/53

Fig.1 A schematic view of the contributions of BCAAs to development of insulin resistance. IR, insulin receptor.

1	Lewis GF, Carpentier A, Adeli K, Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 2002; 23(2): 201-229 doi: 10.1210/er.23.2.201 pmid:11943743
2	Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 2004; 24(2): e13-e18 doi: 10.1161/01.ATV.0000111245.75752.C6 pmid:14766739
3	Rader DJ. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. Am J Med 2007; 120(3 Suppl 1): S12-S18 doi: 10.1016/j.amjmed.2007.01.003 pmid:17320517
4	World Health Organization. Obesity and overweight: Fact sheet N°311. 2012
5	American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009; 32(Suppl 1): S62-S67 doi: 10.2337/dc09-S062 pmid:19118289
6	Layman DK. The role of leucine in weight loss diets and glucose homeostasis. J Nutr 2003; 133(1): 261S-267S pmid:12514305
7	Doi M, Yamaoka I, Nakayama M, Mochizuki S, Sugahara K, Yoshizawa F. Isoleucine, a blood glucose-lowering amino acid, increases glucose uptake in rat skeletal muscle in the absence of increases in AMP-activated protein kinase activity. J Nutr 2005; 135(9): 2103-2108 pmid:16140883
8	Doi M, Yamaoka I, Nakayama M, Sugahara K, Yoshizawa F. Hypoglycemic effect of isoleucine involves increased muscle glucose uptake and whole body glucose oxidation and decreased hepatic gluconeogenesis. Am J Physiol Endocrinol Metab 2007; 292(6): E1683-E1693 doi: 10.1152/ajpendo.00609.2006 pmid:17299083
9	Nishitani S, Takehana K, Fujitani S, Sonaka I. Branched-chain amino acids improve glucose metabolism in rats with liver cirrhosis. Am J Physiol Gastrointest Liver Physiol 2005; 288(6): G1292-G1300 doi: 10.1152/ajpgi.00510.2003 pmid:15591158
10	Cota D, Proulx K, Smith KA, Kozma SC, Thomas G, Woods SC, Seeley RJ. Hypothalamic mTOR signaling regulates food intake. Science 2006; 312(5775): 927-930 doi: 10.1126/science.1124147 pmid:16690869
11	Baum JI, Layman DK, Freund GG, Rahn KA, Nakamura MT, Yudell BE. A reduced carbohydrate, increased protein diet stabilizes glycemic control and minimizes adipose tissue glucose disposal in rats. J Nutr 2006; 136(7): 1855-1861 pmid:16772449
12	Layman DK, Walker DA. Potential importance of leucine in treatment of obesity and the metabolic syndrome. J Nutr 2006; 136(1 Suppl): 319S-323S pmid:16365106
13	Caballero B, Finer N, Wurtman RJ. Plasma amino acids and insulin levels in obesity: response to carbohydrate intake and tryptophan supplements. Metabolism 1988; 37(7): 672-676 doi: 10.1016/0026-0495(88)90089-3 pmid:3290625
14	Felig P, Marliss E, Cahill GF Jr. Plasma amino acid levels and insulin secretion in obesity. N Engl J Med 1969; 281(15): 811-816 doi: 10.1056/NEJM196910092811503 pmid:5809519
15	Felig P, Marliss E, Cahill GF Jr. Are plasma amino acid levels elevated in obesity? N Engl J Med 1970; 282(3): 166 doi: 10.1056/NEJM197001152820315 pmid:5409545
16	Marchesini G, Bianchi G, Rossi B, Muggeo M, Bonora E. Effects of hyperglycaemia and hyperinsulinaemia on plasma amino acid levels in obese subjects with normal glucose tolerance. Int J Obes Relat Metab Disord 2000; 24(5): 552-558 doi: 10.1038/sj.ijo.0801195 pmid:10849575
17	Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, Haqq AM, Shah SH, Arlotto M, Slentz CA, Rochon J, Gallup D, Ilkayeva O, Wenner BR, Yancy WS Jr, Eisenson H, Musante G, Surwit RS, Millington DS, Butler MD, Svetkey LP. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 2009; 9(4): 311-326 doi: 10.1016/j.cmet.2009.02.002 pmid:19356713
18	Shimomura Y, Honda T, Shiraki M, Murakami T, Sato J, Kobayashi H, Mawatari K, Obayashi M, Harris RA. Branched-chain amino acid catabolism in exercise and liver disease. J Nutr 2006; 136(1 Suppl): 250S-253S pmid:16365092
19	Shimomura Y, Obayashi M, Murakami T, Harris RA. Regulation of branched-chain amino acid catabolism: nutritional and hormonal regulation of activity and expression of the branched-chain alpha-keto acid dehydrogenase kinase. Curr Opin Clin Nutr Metab Care 2001; 4(5): 419-423 doi: 10.1097/00075197-200109000-00013 pmid:11568504
20	Sweatt AJ, Wood M, Suryawan A, Wallin R, Willingham MC, Hutson SM. Branched-chain amino acid catabolism: unique segregation of pathway enzymes in organ systems and peripheral nerves. Am J Physiol Endocrinol Metab 2004; 286(1): E64-E76 doi: 10.1152/ajpendo.00276.2003 pmid:12965870
21	Wei J, Xie G, Ge S, Qiu Y, Liu W, Lu A, Chen T, Li H, Zhou Z, Jia W. Metabolic transformation of DMBA-induced carcinogenesis and inhibitory effect of salvianolic acid b and breviscapine treatment. J Proteome Res 2012; 11(2): 1302-1316 doi: 10.1021/pr2009725 pmid:22115128
22	Harris RA, Hawes JW, Popov KM, Zhao Y, Shimomura Y, Sato J, Jaskiewicz J, Hurley TD. Studies on the regulation of the mitochondrial alpha-ketoacid dehydrogenase complexes and their kinases. Adv Enzyme Regul 1997; 37: 271-293 doi: 10.1016/S0065-2571(96)00009-X pmid:9381974
23	Popov KM, Zhao Y, Shimomura Y, Kuntz MJ, Harris RA. Branched-chain alpha-ketoacid dehydrogenase kinase. Molecular cloning, expression, and sequence similarity with histidine protein kinases. J Biol Chem 1992; 267(19): 13127-13130 pmid:1377677
24	Damuni Z, Reed LJ. Purification and properties of the catalytic subunit of the branched-chain alpha-keto acid dehydrogenase phosphatase from bovine kidney mitochondria. J Biol Chem 1987; 262(11): 5129-5132 pmid:3031042
25	Huffman KM, Shah SH, Stevens RD, Bain JR, Muehlbauer M, Slentz CA, Tanner CJ, Kuchibhatla M, Houmard JA, Newgard CB, Kraus WE. Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women. Diabetes Care 2009; 32(9): 1678-1683 doi: 10.2337/dc08-2075 pmid:19502541
26	Shaham O, Wei R, Wang TJ, Ricciardi C, Lewis GD, Vasan RS, Carr SA, Thadhani R, Gerszten RE, Mootha VK. Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Mol Syst Biol 2008; 4: 214 doi: 10.1038/msb.2008.50 pmid:18682704
27	Tai ES, Tan ML, Stevens RD, Low YL, Muehlbauer MJ, Goh DL, Ilkayeva OR, Wenner BR, Bain JR, Lee JJ, Lim SC, Khoo CM, Shah SH, Newgard CB. Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men. Diabetologia 2010; 53(4): 757-767 doi: 10.1007/s00125-009-1637-8 pmid:20076942
28	Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, Lewis GD, Fox CS, Jacques PF, Fernandez C, O’Donnell CJ, Carr SA, Mootha VK, Florez JC, Souza A, Melander O, Clish CB, Gerszten RE. Metabolite profiles and the risk of developing diabetes. Nat Med 2011; 17(4): 448-453 doi: 10.1038/nm.2307 pmid:21423183
29	Floegel A, Stefan N, Yu Z, Muhlenbruch K, Drogan D, Joost HG, Fritsche A, Haring HU, Hrabe de Angelis M, Peters A, Roden M, Prehn C, Wang-Sattler R, Illig T, Schulze MB, Adamski J, Boeing H, Pischon T.Identification of Serum Metabolites Associated With Risk of Type 2 Diabetes Using a Targeted Metabolomic Approach. Diabetes 2012 Oct 4 . [Epub ahead of print] doi: 10.2337/db12-0495 pmid:10.2337/db12-049523043162" target="blank"> doi: 10.2337/db12-049523043162
30	Wang-Sattler R, Yu Z, Herder C, Messias AC, Floegel A, He Y, Heim K, Campillos M, Holzapfel C, Thorand B, Grallert H, Xu T, Bader E, Huth C, Mittelstrass K, D?ring A, Meisinger C, Gieger C, Prehn C, Roemisch-Margl W, Carstensen M, Xie L, Yamanaka-Okumura H, Xing G, Ceglarek U, Thiery J, Giani G, Lickert H, Lin X, Li Y, Boeing H, Joost HG, de Angelis MH, Rathmann W, Suhre K, Prokisch H, Peters A, Meitinger T, Roden M, Wichmann HE, Pischon T, Adamski J, Illig T. Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol 2012; 8: 615 doi: 10.1038/msb.2012.43 pmid:23010998
31	McCormack SE, Shaham O, McCarthy MA, Deik AA, Wang TJ, Gerszten RE, Clish CB, Mootha VK, Grinspoon SK, Fleischman A. Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents. Pediatr Obes 2013; 8(1): 52-61 doi: 10.1111/j.2047-6310.2012.00087.x pmid:22961720
32	Shah SH, Crosslin DR, Haynes CS, Nelson S, Turer CB, Stevens RD, Muehlbauer MJ, Wenner BR, Bain JR, Laferrère B, Gorroochurn P, Teixeira J, Brantley PJ, Stevens VJ, Hollis JF, Appel LJ, Lien LF, Batch B, Newgard CB, Svetkey LP. Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss. Diabetologia 2012; 55(2): 321-330 doi: 10.1007/s00125-011-2356-5 pmid:22065088
33	Laferrère B, Reilly D, Arias S, Swerdlow N, Gorroochurn P, Bawa B, Bose M, Teixeira J, Stevens RD, Wenner BR, Bain JR, Muehlbauer MJ, Haqq A, Lien L, Shah SH, Svetkey LP, Newgard CB. Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss. Sci Transl Med 2011; 3(80):80re2 doi: 10.1126/scitranslmed.3002043 pmid:21525399
34	Luzi L, Castellino P, DeFronzo RA. Insulin and hyperaminoacidemia regulate by a different mechanism leucine turnover and oxidation in obesity. Am J Physiol 1996; 270(2 Pt 1): E273-E281 pmid:8779949
35	Argilés JM, Busquets S, Alvarez B, López-Soriano FJ. Mechanism for the increased skeletal muscle protein degradation in the obese Zucker rat. J Nutr Biochem 1999; 10(4): 244-248 doi: 10.1016/S0955-2863(98)00098-9 pmid:15539297
36	Wang X, Hu Z, Hu J, Du J, Mitch WE. Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology 2006; 147(9): 4160-4168 doi: 10.1210/en.2006-0251 pmid:16777975
37	Suryawan A, Hawes JW, Harris RA, Shimomura Y, Jenkins AE, Hutson SM. A molecular model of human branched-chain amino acid metabolism. Am J Clin Nutr 1998; 68(1): 72-81 pmid:9665099
38	She P, Reid TM, Bronson SK, Vary TC, Hajnal A, Lynch CJ, Hutson SM. Disruption of BCATm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle. Cell Metab 2007; 6(3): 181-194 doi: 10.1016/j.cmet.2007.08.003 pmid:17767905
39	She P, Van Horn C, Reid T, Hutson SM, Cooney RN, Lynch CJ. Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. Am J Physiol Endocrinol Metab 2007; 293(6): E1552-E1563 doi: 10.1152/ajpendo.00134.2007 pmid:17925455
40	Pietil?inen KH, Naukkarinen J, Rissanen A, Saharinen J, Ellonen P, Ker?nen H, Suomalainen A, G?tz A, Suortti T, Yki-J?rvinen H, Oresic M, Kaprio J, Peltonen L. Global transcript profiles of fat in monozygotic twins discordant for BMI: pathways behind acquired obesity. PLoS Med 2008; 5(3): e51 doi: 10.1371/journal.pmed.0050051 pmid:18336063
41	Herman MA, She P, Peroni OD, Lynch CJ, Kahn BB. Adipose tissue branched chain amino acid (BCAA) metabolism modulates circulating BCAA levels. J Biol Chem 2010; 285(15): 11348-11356 doi: 10.1074/jbc.M109.075184 pmid:20093359
42	Hsiao G, Chapman J, Ofrecio JM, Wilkes J, Resnik JL, Thapar D, Subramaniam S, Sears DD. Multi-tissue, selective PPARγ modulation of insulin sensitivity and metabolic pathways in obese rats. Am J Physiol Endocrinol Metab 2011; 300(1): E164-E174 doi: 10.1152/ajpendo.00219.2010 pmid:20959535
43	Sears DD, Hsiao G, Hsiao A, Yu JG, Courtney CH, Ofrecio JM, Chapman J, Subramaniam S. Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization. Proc Natl Acad Sci USA 2009; 106(44): 18745-18750 doi: 10.1073/pnas.0903032106 pmid:19841271
44	Lefort N, Glancy B, Bowen B, Willis WT, Bailowitz Z, De Filippis EA, Brophy C, Meyer C, H?jlund K, Yi Z, Mandarino LJ. Increased reactive oxygen species production and lower abundance of complex I subunits and carnitine palmitoyltransferase 1B protein despite normal mitochondrial respiration in insulin-resistant human skeletal muscle. Diabetes 2010; 59(10): 2444-2452 doi: 10.2337/db10-0174 pmid:20682693
45	Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev 2004; 18(16): 1926-1945 doi: 10.1101/gad.1212704 pmid:15314020
46	Hara K, Maruki Y, Long X, Yoshino K, Oshiro N, Hidayat S, Tokunaga C, Avruch J, Yonezawa K. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 2002; 110(2): 177-189 doi: 10.1016/S0092-8674(02)00833-4 pmid:12150926
47	Haruta T, Uno T, Kawahara J, Takano A, Egawa K, Sharma PM, Olefsky JM, Kobayashi M. A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1. Mol Endocrinol 2000; 14(6): 783-794 doi: 10.1210/me.14.6.783 pmid:10847581
48	O’Connor JC, Freund GG. Vanadate and rapamycin synergistically enhance insulin-stimulated glucose uptake. Metabolism 2003; 52(6): 666-674 doi: 10.1016/S0026-0495(03)00026-X pmid:12800089
49	Pederson TM, Kramer DL, Rondinone CM. Serine/threonine phosphorylation of IRS-1 triggers its degradation: possible regulation by tyrosine phosphorylation. Diabetes 2001; 50(1): 24-31 doi: 10.2337/diabetes.50.1.24 pmid:11147790
50	Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA, Cahill DA, Goldstein BJ, White MF. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 1991; 352(6330): 73-77 doi: 10.1038/352073a0 pmid:1648180
51	Tzatsos A, Kandror KV. Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation. Mol Cell Biol 2006; 26(1): 63-76 doi: 10.1128/MCB.26.1.63-76.2006 pmid:16354680
52	Tremblay F, Krebs M, Dombrowski L, Brehm A, Bernroider E, Roth E, Nowotny P, Waldh?usl W, Marette A, Roden M. Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability. Diabetes 2005; 54(9): 2674-2684 doi: 10.2337/diabetes.54.9.2674 pmid:16123357
53	Xiao F, Huang Z, Li H, Yu J, Wang C, Chen S, Meng Q, Cheng Y, Gao X, Li J, Liu Y, Guo F. Leucine deprivation increases hepatic insulin sensitivity via GCN2/mTOR/S6K1 and AMPK pathways. Diabetes 2011; 60(3): 746-756 doi: 10.2337/db10-1246 pmid:21282364
54	Bruhat A, Jousse C, Fafournoux P. Amino acid limitation regulates gene expression. Proc Nutr Soc 1999; 58(3): 625-632 doi: 10.1017/S0029665199000828 pmid:10604196
55	Kilberg MS, Pan YX, Chen H, Leung-Pineda V. Nutritional control of gene expression: how mammalian cells respond to amino acid limitation. Annu Rev Nutr 2005; 25(1): 59-85 doi: 10.1146/annurev.nutr.24.012003.132145 pmid:16011459
56	Guo F, Cavener DR. The GCN2 eIF2alpha kinase regulates fatty-acid homeostasis in the liver during deprivation of an essential amino acid. Cell Metab 2007; 5(2): 103-114 doi: 10.1016/j.cmet.2007.01.001 pmid:17276353
57	Macotela Y, Emanuelli B, B?ng AM, Espinoza DO, Boucher J, Beebe K, Gall W, Kahn CR. Dietary leucine—an environmental modifier of insulin resistance acting on multiple levels of metabolism. PLoS ONE 2011; 6(6): e21187 doi: 10.1371/journal.pone.0021187 pmid:21731668
58	Zhang Y, Guo K, LeBlanc RE, Loh D, Schwartz GJ, Yu YH. Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms. Diabetes 2007; 56(6): 1647-1654 doi: 10.2337/db07-0123 pmid:17360978
59	Nairizi A, She P, Vary TC, Lynch CJ. Leucine supplementation of drinking water does not alter susceptibility to diet-induced obesity in mice. J Nutr 2009; 139(4): 715-719 doi: 10.3945/jn.108.100081 pmid:19244380

[1]	Ruiting Han, Junli Ma, Houkai Li. Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota[J]. Front. Med., 2018, 12(6): 645-657.
[2]	Lixia Gan,Wei Xiang,Bin Xie,Liqing Yu. Molecular mechanisms of fatty liver in obesity[J]. Front. Med., 2015, 9(3): 275-287.
[3]	Juan Zheng,Shih-Lung Woo,Xiang Hu,Rachel Botchlett,Lulu Chen,Yuqing Huo,Chaodong Wu. Metformin and metabolic diseases: a focus on hepatic aspects[J]. Front. Med., 2015, 9(2): 173-186.
[4]	Jianping Ye. Beneficial metabolic activities of inflammatory cytokine interleukin 15 in obesity and type 2 diabetes[J]. Front. Med., 2015, 9(2): 139-145.
[5]	Xiao Miao, Weixia Sun, Yaowen Fu, Lining Miao, Lu Cai. Zinc homeostasis in the metabolic syndrome and diabetes[J]. Front Med, 2013, 7(1): 31-52.
[6]	Fang-Ping LI, Zhi-Zhen LI, Miao ZHANG, Li YAN, Zu-Zhi FU. Effects of resistin on skeletal glucose metabolism[J]. Front Med Chin, 2010, 4(3): 329-335.
[7]	Hui SUN MD, Xiuling DENG MM, Fangxi XIAO MD, Lulu CHEN MD, Huiqing LI MD, . Role of exercise training on insulin resistance and TNF-α in high-fat diet rats[J]. Front. Med., 2009, 3(4): 403-407.
[8]	XIA Yanzhi, WAN Xuedong, DUAN Qiuhong, HE Shansu, WANG Ximing. Inhibition of protein kinase B by Palmitate in the insulin signaling of HepG2 cells and the preventive effect of Arachidonic acid on insulin resistance[J]. Front. Med., 2007, 1(2): 200-206.

Viewed

Full text

Abstract

Cited

Shared

Discussed